Jacqueline Garonzik Wang, MD, PhD

Associate Professor

  • Division of Transplantation
  • Surgical Director of UW Health Kidney Transplant Program

garonzikwang@surgery.wisc.edu
608-265-6471

H4/766
600 Highland Ave
Madison, WI 53792

Education

  • MD, Emory University, 2002
  • Resident, John Hopkins Hospital, Surgery, 2014
  • Research Fellowship, Johns Hopkins Hospital, Transplant Surgery, 2012
  • PhD, Johns Hopkins Bloomberg School of Public Health, 2014
  • Fellowship, Washington University, Abdominal Transplant Surgery, 2016

Clinical Specialties

Dr. Garonzik Wang is certified by the American Board of Surgery (ABS), the American Society of Transplant Surgeons (ASTS) and the Americas Hepato-Pancreato-Bilairy Assocaition (AHPBA). She specializes in liver, kidney and pancreas transplantation and living kidney and liver donation.

Research Interests

Dr. Garonzik Wang’s research focuses on identifying novel strategies to increase rates of deceased and living donor kidney transplantation. She is also actively investigating the effects of COVID-19 in solid organ transplant recipients and studying methods to improve SARS-CoV-2 vaccine response rates in immunosuppressed individuals.

Recent Publications

  • Multi-center study of racial & ethnic inequities in liver transplant evaluation: understanding mechanisms & identifying solutions.
    Strauss AT, Sidoti CN, Purnell TS, Sung HC, Jackson JW, Levin S, Jain VS, Malinsky D, Segev DL, Hamilton JP, Garonzik-Wang J, Gray SH, Levan ML, Scalea JR, Cameron AM, Gurakar A, Gurses AP
    Liver Transpl 2022 Jun 21;
    [PubMed ID: 35726679]

  • Improved humoral immunogenicity with mRNA-1273 versus BNT162b2 as third vaccine dose among solid organ transplant recipients seronegative after two BNT162b2 doses.
    Chang A, Chiang TP, Kim JD, Mitchell J, Alejo JL, Jefferis AA, Avery RK, Tobian AAR, Levan ML, Warren DS, Garonzik-Wang JM, Massie AB, Segev DL, Werbel WA
    Clin Transplant 2022 Jun 07; e14738
    [PubMed ID: 35670813]

  • Incidence and Severity of COVID-19 Among Vaccinated Solid Organ Transplant Recipients During the Omicron Wave.
    Alejo JL, Chiang TPY, Bowles Zeiser L, Kim JD, Mitchell J, Avery RK, Tobian AAR, Abedon RR, Levan ML, Warren DS, Garonzik-Wang JM, Massie AB, Segev DL, Werbel WA
    Transplantation 2022 Jun 03;
    [PubMed ID: 35655363]

  • Antibody response to three SARS-CoV-2 mRNA vaccines in adolescent solid organ transplant recipients.
    Qin CX, Auerbach SR, Charnaya O, Danziger-Isakov LA, Ebel NH, Feldman AG, Hsu EK, McAteer J, Mohammad S, Perito ER, Thomas AM, Chiang TPY, Garonzik-Wang JM, Segev DL, Mogul DB
    Am J Transplant 2022 May 05;
    [PubMed ID: 35510786]

  • Heterologous Ad.26.COV2.S versus homologous BNT162b2/mRNA-1273 as a third dose in solid organ transplant recipients seronegative after two-dose mRNA vaccination.
    Chiang TP, Alejo JL, Mitchell J, Kim JD, Abedon AT, Karaba AH, Thomas L, Levan ML, Garonzik-Wang JM, Avery RK, Pekosz A, Clarke WA, Warren DS, Tobian AAR, Massie AB, Segev DL, Werbel WA
    Am J Transplant 2022 Apr 16;
    [PubMed ID: 35429211]

All Publications on PubMed